Abstract:Due to their very potent antimicrobial activity against diverse food-spoiling bacteria and pathogens and their favourable biochemical properties, peptide bacteriocins from Gram-positive bacteria have long been considered promising for applications in food preservation or medical treatment. To take advantage of bacteriocins in different applications, it is crucial to have detailed knowledge on the molecular mechanisms by which these peptides recognize and kill target cells, how producer cells protect themselves… Show more
“…In S. mutans, several class II bacteriocins are expressed through the CSP-ComDE quorum-sensing system (16,26,48). Class II bacteriocins are antimicrobial peptides that function to kill competitors by dissipating the proton motive force via pore formation in the cytoplasmic membrane of target cells (23). Interestingly, preliminary work done in our lab demonstrated that inactivation of mutacin V (CipB), but not mutacin IV (NlmAB), completely abolished the increase in persister numbers observed for the WT strain following pretreatment with the CSP pheromone.…”
Within a given microbial population, a small subpopulation known as dormant persister cells exists. This persistence property ensures the survival of the population as a whole in the presence of lethal factors. Although persisters are highly important in antibiotic therapy, the mechanism for persistence is still not thoroughly understood. We show here that the cariogenic organism
Streptococcus mutans
forms persister cells showing noninherited multidrug tolerance. We demonstrated that the ectopic expression of the type II toxin-antitoxin systems, MazEF and RelBE, caused an increase in the number of persisters. In a search for additional persistence genes, an expression library was constructed, and several clones exhibiting a significant difference in persister formation after prolonged antibiotic treatment were selected. The candidate persister genes include genes involved in transcription/replication, sugar metabolism, cell wall synthesis, and energy metabolism, clearly pointing to redundant pathways for persister formation. We have previously reported that the
S. mutans
quorum-sensing peptide, CSP pheromone, was a stress-inducible alarmone capable of conveying sophisticated messages in the bacterial population. In this study, we demonstrate the involvement of the intraspecies quorum-sensing system during the formation of stress-induced multidrug-tolerant persisters. To the best of our knowledge, this is the first study reporting the induction of bacterial persistence using a quorum-sensing regulatory system.
“…In S. mutans, several class II bacteriocins are expressed through the CSP-ComDE quorum-sensing system (16,26,48). Class II bacteriocins are antimicrobial peptides that function to kill competitors by dissipating the proton motive force via pore formation in the cytoplasmic membrane of target cells (23). Interestingly, preliminary work done in our lab demonstrated that inactivation of mutacin V (CipB), but not mutacin IV (NlmAB), completely abolished the increase in persister numbers observed for the WT strain following pretreatment with the CSP pheromone.…”
Within a given microbial population, a small subpopulation known as dormant persister cells exists. This persistence property ensures the survival of the population as a whole in the presence of lethal factors. Although persisters are highly important in antibiotic therapy, the mechanism for persistence is still not thoroughly understood. We show here that the cariogenic organism
Streptococcus mutans
forms persister cells showing noninherited multidrug tolerance. We demonstrated that the ectopic expression of the type II toxin-antitoxin systems, MazEF and RelBE, caused an increase in the number of persisters. In a search for additional persistence genes, an expression library was constructed, and several clones exhibiting a significant difference in persister formation after prolonged antibiotic treatment were selected. The candidate persister genes include genes involved in transcription/replication, sugar metabolism, cell wall synthesis, and energy metabolism, clearly pointing to redundant pathways for persister formation. We have previously reported that the
S. mutans
quorum-sensing peptide, CSP pheromone, was a stress-inducible alarmone capable of conveying sophisticated messages in the bacterial population. In this study, we demonstrate the involvement of the intraspecies quorum-sensing system during the formation of stress-induced multidrug-tolerant persisters. To the best of our knowledge, this is the first study reporting the induction of bacterial persistence using a quorum-sensing regulatory system.
“…The immunity proteins do not prevent the formation of bacteriocin-receptor complex by binding to the receptors competitively. (Kjos et al 2011). As a side effect, glucose transport is also blocked, leading to the reduced growth on glucose.…”
Section: ) As Hydrophobic Interactions Are Normally Involved In mentioning
confidence: 99%
“…In immune cells (b), the bacteriocin mediates the same conformational changes, but the pore is blocked by a specific immunity protein (dark blue) which tightly binds to EII t Man -bacteriocin complex. Adapted from Kjos et al (2011).…”
Section: ) As Hydrophobic Interactions Are Normally Involved In mentioning
confidence: 99%
“…Class IIa bacteriocins permeabilise the target cells by forming pores in the cytoplasmic membrane that subsequently leads to the depletion of the intracellular ATP pool, disturbance of the proton motif force and eventually the cell death Suzuki et al 2005). After contacting the receptor molecule mannose phosphotransferase system (PTS) permease EII t Man on cell membrane, the N-terminal halves of these bacteriocins form a three-stranded anti-parallel β-sheet-like structure which stabilises the binding to the receptor on the target cell membrane (Kjos et al 2011). Simultaneously, the helical C-termini penetrate into the receptor protein (Johnsen et al 2005a).…”
“…Bacteriocins are found in both Gram-positive and Gram-negative bacteria, and together, they constitute a large and diverse group of antimicrobial peptides and proteins. Within the Gram-positive bacteria, particularly LAB, bacteriocins are found abundantly and have been extensively studied with respect to structure, diversity, mode of action, production, and target specificity (5). Bacteriocins have been divided into three classes: class I, lantibiotics, which are small and heavily modified peptides containing lanthionine residues; class II, unmodified bacteriocins, which are small, unmodified peptides or peptides with minor modifications (such as sulfide bridges); and class III, lytic and relatively large proteins (6).…”
A novel antimicrobial peptide designated enterocin O16 was purified from Enterococcus faecalis. Mass spectrometry showed a monoisotopic mass of 7,231 Da, and N-terminal Edman degradation identified a 29-amino-acid sequence corresponding to residues 90 to 119 of the EF_1097 protein. Bioinformatic analysis showed that enterocin O16 is composed of the 68 most C-terminal residues of the EF_1097 protein. Introduction of an in-frame isogenic deletion in the ef1097 gene abolished the production of enterocin O16. Enterocin O16 has a narrow inhibitory spectrum, as it inhibits mostly lactobacilli. Apparently, E. faecalis is intrinsically resistant to the antimicrobial peptide, as no immunity connected to the production of enterocin O16 could be identified. ef1097 has previously been identified as one of three loci regulated by the fsr quorum-sensing system. The introduction of a nonsense mutation into fsrB consistently impaired enterocin O16 production, but externally added gelatinase biosynthesis-activating pheromone restored the antimicrobial activity. Functional genetic analysis showed that the EF_1097 proprotein is processed extracellularly into enterocin O16 by the metalloprotease GelE. Thus, it is evident that the fsr quorum-sensing system constitutes the regulatory unit that controls the expression of the EF_1097 precursor protein and the protease GelE and that the latter is required for the formation of enterocin O16. On the basis of these results, this study identified antibacterial antagonism as a novel aspect related to the function of fsr and provides a rationale for why ef1097 is part of the fsr regulon.
IMPORTANCEThe fsr quorum-sensing system modulates important physiological functions in E. faecalis via the activity of GelE. The present study presents a new facet of fsr signaling. The system controls the expression of three primary target operons (fsrABCD, gelEsprE, and ef1097-ef1097b). We demonstrate that the concerted expression of these operons constitutes the elements necessary for the production of a bacteriocin-type peptide and that antimicrobial antagonism is an intrinsic function of fsr. The bacteriocin enterocin O16 consists of the 68 most C-terminal residues of the EF_1097 secreted proprotein. The GelE protease processes the EF_1097 proprotein into enterocin O16. In this manner, fsr signaling enables E. faecalis populations to express antimicrobial activity in a cell density-dependent manner. E nterococci are among the most common commensal lactic acid bacteria (LAB) in the gastrointestinal (GI) tracts of humans and animals. Throughout our lives, we receive frequent supplies of enterococci, especially from fermented foods (dairy, meat, and vegetable based). While some enterococci seem to establish themselves as part of the GI microbiota, most enterococcal strains only transiently inhabit the GI system. Enterococci are also prominent etiological agents of nosocomial infections (1). The increasing incidence of multiple-antibiotic-resistant nosocomial isolates makes the treatment of infection...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.